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Abstract We examined whether there is a correlation
among early embryo cleavage, speed of cleavage, and
implantation potential for in-vitro fertilization (IVF) treat-
ment and intracytoplasmic sperm injection (ICSI). This ret-
rospective study examined 112 cycles of IVF and 82 cycles
of ICSI in patients less than 40 years of age. Early cleavage
was defined as embryonic mitosis occurring 25–27 h after
insemination. These day-3 embryos were then grouped
according to cleavage speed (rapid, normal, and slow) and
morphological quality (good or poor). A larger proportion of
early-cleavage embryos developed normally compared to
non-early-cleavage embryos (IVF: 69.1 % vs. 47.1 %,
respectively; ICSI: 63.0 % vs. 45.6 %, respectively). The
early-cleavage embryos also produced more good quality
embryos than the non-early-cleavage embryos (IVF: 80.2 %
vs. 56.4 %, respectively; ICSI: 73.4 % vs. 59.4 %). The
implantation rate was significantly higher with early-
cleavage embryos in both IVF (42.9 % vs. 19.7 %) and
ICSI (48.1 % vs. 24 %). These results indicate that early-
cleavage embryos have a higher rate of normal development
and develop into better quality embryos on day 3, resulting
in more and higher quality embryos to choose from for day-
3 embryo transfer. Thus, early cleavage may be a useful
criterion when selecting embryos for IVF or ICSI.
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Summary
Embryo selection is a difficult task on the embryo transfer day.
Many parameters can be used to make this decision, including
useful tools such as pronuclear morphology, Early cleavage
(EC), blastomere morphology, and blastocyst grading. The
clinical outcome of EC embryos should be evaluated when
using the elective single embryo transfer (eSET) and double
embryo transfer (DET) methods. In our study, we proved that
for IVF, EC embryos (without mixed embryos) develop more
normal cleavage and good quality embryos on day 3, and the
selection of these embryos during IVF results in better clinical
outcomes. Therefore, for IVF, identifying EC embryos is a
useful tool for embryo selection. For the ICSI group, a better
implantation rate was found by using EC embryos; the differ-
ences in the pregnancy and live birth rates were not statisti-
cally significant. Therefore, for ICSI, EC embryos should be
identified 2 h earlier than for IVF to make this predictive
marker more accurate. The use of EC as a marker for improv-
ing rates of pregnancy and live birth should be further inves-
tigated in ICSI cycles.
Introduction
The identification of viable embryos is important for assisted
reproductive therapy. Many embryo scoring or grading sys-
tems have been developed for choosing the best and most
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viable embryos. Oocyte and pronuclei morphology, blasto-
mere number and symmetry, fragmentation, and blastocyst
morphology are the usual criteria for selecting the best
embryos at each stage [1, 2, 18]. Furthermore, several studies
have shown that early cleavage (EC), defined as being 25–27 h
after in vitro fertilization (IVF)/intracytoplasmic sperm injec-
tion (ICSI), is a strong indicator of embryo viability [2, 4–8].
In a previous study [9], the relationship between EC and
day-2 embryo scores was evaluated; it was found that
embryos with even EC developed into good day-2 embryos
more often than those at the pronuclei or syngamy stages
(ICSI: 69 % vs. 34 % and 29 %, respectively; IVF: 53 % vs.
37 % and 29 %, respectively). Even and mononucleated EC
embryos had higher day-3 scores [8]. The blastocyst forma-
tion rate of EC embryos was higher than that of non-EC
embryos (66 % vs. 40 %; 32.2 % vs. 16.6 %) [10, 11].
Many studies have compared EC embryos to non-EC
embryos without distinguishing between IVF or ICSI cycles
[3–5, 7, 12, 14–16]. In theory, the oocyte is fertilized earlier by
the sperm in ICSI compared with IVF treatment because the
spermatozoon is directly injected into the oocyte. Therefore, the
EC rate should be higher in the ICSI cycle than the IVF cycle
(34.7 % vs. 21.5 %) [3]. Van Montfoort et al. [7] evaluated EC
2 h earlier in the ICSI cycle. In this study, the outcomes of EC
embryos were evaluated in both the IVF and ICSI cycles.
Furthermore, the outcome of EC embryo implantation
should be evaluated when the elective single embryo transfer
(eSET) method is used. Transferring mixed embryos (EC and
non-EC) would affect the predictive value of EC. Some studies
have evaluated the predictive value of EC after using mixed EC
and non-EC embryos in IVF and ICSI cycles [3, 4, 17]. Other
studies have evaluated the predictive value of EC using eSET
but did not differentiate between IVF and ICSI cycles [5, 7, 14,
15]. These studies found that EC embryos had higher implan-
tation and pregnancy rates. However, no studies have evaluated
EC embryos using eSET in only IVF treatment cycles. There-
fore, we selected treatment cycles that did not transfer mixed
EC and non-EC embryos together in order to evaluate the
outcomes of EC embryos.
The aim of this study was to assess the relationship
between EC and day-3 embryonic blastomere number and
quality in IVF and ICSI cycles. The rates of implantation,
clinical pregnancy, and live birth were also recorded to
evaluate the outcomes of EC embryo transfer in both cycles.
Materials and methods
Study subjects
This study was a retrospective study of IVF/ICSI outcomes
based on the medical records of 185 patients (112 IVF
cycles and 82 ICSI cycles) in the IVF laboratory of Mackay
Memorial Hospital from December 2007 to November
2008. To minimize age-related effects, patients over 40 years
of age were excluded from the study.
Ovarian stimulation protocols
Two stimulation protocols were used: the gonadotropin-
releasing hormone (GnRH) agonist long protocol (GnRH ago-
nist group) and the GnRH antagonist protocol (GnRH antag-
onist group). In the GnRH agonist group, 0.5 mg (0.1 cc) of
leuprolide acetate (Lupron, Takeda, Germany) was adminis-
tered daily, commencing on day 21 of the previous menstrual
cycle. Once serum levels of estradiol (E2)<40 pg/ml were
achieved, recombinant follicle-stimulating hormone (FSH;
Gonal-F; Serono, Switzerland) and human menopausal gona-
dotropin (hMG; Menopur; Ferring, Germany) were adminis-
tered from the third day of menstruation until the day of human
chorionic gonadotropin (hCG) administration. The doses were
adjusted according to each patient’s ovarian response. In the
GnRH antagonist group, recombinant FSH and hMG were
administered daily from the third day of the menstrual cycle.
The doses were also adjusted according to each patient’s
individual ovarian response. Once the dominant follicle
reached 14 mm in mean diameter, 0.25 mg cetrorelix acetate
(Cetrotide; Serono, Germany) was administered subcutane-
ously daily until the day of hCG administration.
In both groups, final maturation was induced using ether
recombinant hCG (Ovidrel; Serono, Italy) or urinary hCG
(Profasi; Serono, Switzerland) when at least 2 leading fol-
licles reached 18 mm in diameter; oocyte retrieval was
performed 34–36 h later. On day 3, the embryos were
graded morphologically, and embryo transfer was per-
formed 72 h after oocyte retrieval. In each stimulation pro-
tocol, patients in whom only EC embryos were transferred
were designated the “early-cleavage” subgroup. Patients in
whom no EC embryos were transferred were designated as
the “non-early-cleavage” subgroup.
The luteal phase was supported by vaginal supplementa-
tion of Crinone (8 % progesterone, 1.125 g applicator;
Serono, UK) or intramural injection of 50 mg progesterone
once a day. To assess treatment outcome, serum hCG was
measured 14 days after oocyte retrieval. Clinical pregnancy
was defined as the observation of a gestational sac in the
uterus by transvaginal ultrasonography. The live birth rate
was defined as the live birth of one or more neonates.
Insemination and ICSI
Male factor infertility patients with a sperm concentration of
<10×106/mL, motility <25 %, or normal morphologic
sperm (Kruger’s strict criteria) <4 % received ICSI as treat-
ment, whereas those without male factor infertility received
conventional IVF treatment.
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Either IVF or ICSI was performed 3–5 h after oocyte
aspiration. For the IVF procedure, each oocyte was insemi-
nated with 20×103 motile spermatozoa in a single drop of
20 μl medium (Quinn’s Advantage Fertilization medium;
SAGE IVF, Trumbull, CT, USA). For the ICSI procedure,
1–2 μl washed spermatozoa was placed in 7 % polyvinylpyr-
rolidone (PVP; SAGE IVF) and the sperm was injected using
standard techniques. Each embryo was cultured in a single
drop of 20μl medium (Quinn’s Advantage Cleavagemedium;
SAGE IVF) supplemented with 10 % synthetic serum sub-
stitute (Quinn’s Advantage Serum Protein Substitute; SAGE
IVF) that was covered with mineral oil (SAGE IVF) in an
atmosphere of 5 % O2, 5 % CO2, and 90 %N2 at 37 °C.
Assessment of fertilization, early cleavage, and embryo
quality
Normal fertilization was confirmed by the presence of 2 pro-
nuclei and 2 polar bodies 16–20 h (day 1) after IVF or ICSI. On
the same day, EC examination was performed 25–27 h after
IVF or ICSI. Embryos displaying 2 cells at inspection were
considered EC embryos, whereas those that had not yet cleaved
to the 2-cell stage were designated non-EC embryos. Embryos
were further examined for their quality at 66–68 h (day 3) after
IVF or ICSI. Day-3 embryos were classified according to
blastomere number as follows: rapid cleavage (≥9 cells), nor-
mal cleavage (7–8 cells), or slow cleavage (≤6 cells). On the
basis of quality, day-3 embryos were grouped into good
embryos (<20 % fragmentation and an even blastomere) or
poor embryos (>20 % fragmentation or an uneven blastomere).
Statistical analysis
Statistical analysis was performed using SPSS software
version 12.0 for Windows. The differences in means
between 2 variables were calculated using the Mann–
Whitney U test and unpaired t test. The differences in
the rates of implantation, clinical pregnancy, abortion,
live birth, and EC were calculated using the chi-square
test. A P value of <0.05 was considered statistically
significant.
Results
A total of 194 treatment cycles were analyzed, 112 using
IVF and 82 using ICSI. The cycle characteristics for IVF or
ICSI are shown in Table 1. The age differences of patients
who received IVF or ICSI were not statistically significant
(34.0±3.34 vs. 33.4±3.60, respectively). There were 699 2-
pronuclear (2PN) zygotes in the IVF cycles and 522 2PN
zygotes in the ICSI cycles. The EC rate was higher in ICSI
than IVF (36.8 % vs. 31.0 %, respectively; P00.041).
The relationship between EC and day-3 embryonic
development in IVF and ICSI cycles was assessed (Tables 2
and 3, respectively). For IVF, there were 217 embryos in the
EC group and 482 embryos in the non-EC group. The
normal cleavage rate was 69.1 % for EC embryos and
47.1 % for non-EC embryos (P<0.05). The incidence of
good embryos was 80.2 % in the EC group and 56.4 % in
the non-EC group (P<0.05). For ICSI, the EC group had
192 embryos and the non-EC group had 330 embryos. The
normal cleavage rate was 63.0 % for the EC group and
45.6 % in the non-EC group (P<0.05). The incidence of
good embryos was 73.4 % for the EC group and 59.4 % for
the non-EC group (P<0.05).
In Tables 4 and 5, “EC group” implies that only EC
embryos were transferred to the uterus, and “non-EC group”
implies that only non-EC embryos were transferred to the
uterus. Using IVF, 16 cycles were performed for the EC
Table 1 Comparisons of the early cleavage rate and the non-early
cleavage rate for IVF and ICSI cycles. NS: no statistically significantly
IVF ICSI P value
No. of cycles 112 82
Age (mean ± SD) 34.0±3.34 33.4±3.6 NS
Total 2PN 699 522
Early cleavage (%) 217 (31.0) 192 (36.8) 0.041
Non-early cleavage (%) 482 (69.0) 330 (63.2) 0.041
Table 2 Embryonic development and quality of embryos in the IVF
group
Embryonic development EC Non-EC P value
No. of embryos: 217 482
≥9 cells, rapid cleavage (%) 35 (16.1) 41 (8.5) <0.05
7–8 cells, normal cleavage (%) 150 (69.1) 227 (47.1) <0.05
≤6 cells, slow cleavage (%) 32 (14.7) 214 (44.4) <0.05
Quality of embryos:
Good embryos (%) 174 (80.2) 272 (56.4) <0.05
Poor embryos (%) 43 (19.8) 210 (43.6) <0.05
Table 3 The embryonic development and the quality of embryos in
ICSI group
Embryonic development EC Non-EC P value
No. of embryos: 192 330
≥9 cells, rapid cleavage (%) 31 (16.1) 28 (8.5) <0.05
7–8cells, normal cleavage (%) 121 (63.0) 149 (45.6) <0.05
≤6 cells, slow cleavage (%) 40 (20.8) 153 (46.4) <0.05
Quality of embryos:
Good embryos (%) 141 (73.4) 196 (59.4) <0.05
Poor embryos (%) 51 (26.6) 134 (40.6) <0.05
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group and 48 cycles for the non-EC group. For the IVF
cycles, there was no statistical significance with regard to
the duration of stimulation, number of embryos transferred,
or abortion rate. The peak E2 level (P<0.05), number of
oocytes retrieved (P<0.05), number of mature oocytes (P<
0.05), number of 2PN zygotes (P<0.05), clinical pregnancy
rate (P<0.05), and implantation rate (P<0.05) were signifi-
cantly higher in the EC group than in the non-EC group. The
live birth rate was significantly higher in the EC group than
in the non-EC group (62.5 % vs. 25.0 %, P<0.05). For the
ICSI cycles, there was no statistical significance with regard
to age, duration of stimulation, FSH dosage, peak E2 level,
number of oocytes retrieved, number of mature oocytes,
number of 2PN zygotes, number of embryos transferred,
or abortion rate. The implantation rate was statistically
higher in the EC group than in the non-EC group (48.1 %
vs. 24.0 %, P0P<0.05). The live birth rate was higher in the
EC group than in the non-EC group (54.5 % vs. 37.1 %) but
was not statistically significant.
Discussion
Many factors can influence the outcomes of IVF treatment or
ICSI, but embryo morphology is the most common and useful
tool in selecting the best embryos for transfer. Because eSET
and double embryo transfer (DET) procedures have been
recently recommended, choosing good quality embryos to
enhance the rates of implantation, pregnancy, and live birth is
very important. The use of EC identification to select embryos
in humans was first reported by Edwards et al. [13]. Several
studies have confirmed that EC is a strong indicator for viable
embryo selection in humans [3–11]. In particular, using the
eSET method with EC embryos results in higher implantation
and pregnancy rates than those obtained using the eSET
method with non-EC embryos [5, 7, 15]. The influence of EC
on the live birth rate has been controversial. Emiliani et al. [14]
claimed that assessing EC did not improve the delivery rate of
single embryo transfer, although Lundin et al. [3] showed that
EC was an independent predictor of birth in ICSI cycles.
Table 4 Comparison of trans-
ferred embryos with only early-
cleavage and non-early-cleavage
embryos for the IVF group
EC Non-EC P value
No. of cycles 16 48
Age range (years; mean ± SD) 32.1±3.2 34.1±3.4 <0.05
Duration of stimulation (days) 11.06±1.3 11.52±2.4 0.71
FSH dosage 1890.00±1160.2 2649.27±1221.0 <0.05
Peak E2 level 3011.56±1324.4 1781.98±1167.2 <0.05
No. of oocyte retrieved 13.43±5.3 7.56±4.7 <0.05
No. of mature oocytes 12.44±5.5 6.50±4.4 <0.05
No. of 2PN (total) 9.50±5.6 4.45±3.3 <0.05
No. of embryos transferred 2.62±0.7 2.65±1.0 0.89
Clinical pregnancies (%) 12/16 (75) 18/48 (37.5) <0.05
Implantations (%) 18/42 (42.9) 25/127 (19.7) <0.05
Abortions (%) 3/12 (25) 2/18 (11.1) 0.36
Live births (%) 10/16 (62.5) 12/48 (25.0) <0.05
Table 5 Comparison of trans-
ferred embryos with only early
cleavage and non-early cleavage
in the ICSI group
EC Non-EC P value
No. of cycles 22 35
Age range (years; mean ± SD) 32.77±3.1 33.34±4.1 0.49
Duration of stimulation (days) 11.68±2.1 11.49±1.8 0.81
FSH dosage 1969.09±1382.4 2521.57±1261.8 <0.05
Peak E2 level 2185.18±1591.5 2306.94±1619.8 0.75
No. of oocyte retrieved 10.86±5.25 10.14±5.93 0.55
No. of mature oocytes 9.27±4.8 8.26±5.1 0.47
No. of 2PN (total) 6.73±4.6 6.06±4.29 0.61
No. of embryos transferred 2.45±0.7 2.74±1.0 0.18
Clinical pregnancies (%) 15/22 (68.2) 18/35 (51.4) 0.27
Implantations (%) 26/54 (48.1) 23/96 (24.0) <0.05
Abortions (%) 3/15 (20.0) 5/18 (27.8) 0.70
Live births (%) 12/22 (54.5) 13/35 (37.1) 0.27
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Day-1 embryo development may be assessed by observ-
ing pronuclear morphology or EC, and day-3 morphology
may be assessed by evaluating the number and morphology
of blastomeres, including the percentage of fragmentation
and even blastomeres. Terriou et al. [9] claimed that even
EC embryos are strongly associated with good embryo
morphology (53 % in IVF, 69 % in ICSI). EC embryos also
show higher rates of blastocyst formation (66 % in both IVF
and ICSI) [10]. We evaluated the correlation between EC
embryos and day-3 embryo development. Normal cleavage
rates were 69.1 % for IVF and 63.0 % for ICSI. Good
embryo rates were 80.2 % for IVF and 73.4 % for ICSI.
These results were statistically significantly higher than
those obtained using non-EC embryos. Therefore, for both
IVF and ICSI, more EC embryos developed into embryos
with a normal cleavage rate and good morphology on day 3.
These identified embryos should be selected for transfer to
enhance the pregnancy rate.
The outcomes of using EC embryos were also evaluated by
assessing the rates of clinical pregnancy, implantation, abor-
tion, and live birth. The EC group had statistically higher
implantation rates than the non-EC group in both the IVF
and ICSI cycles. There was no difference in the abortion rate
between the groups for the 2 cycles. Interestingly, the clinical
pregnancy and live birth rates were statistically significantly
higher for the EC group than the non-EC group for the IVF
cycles but not statistically higher for the ICSI cycles.
The data showing the relationship among EC embryos,
day-3 embryonic development, and clinical outcomes were
divided into the IVF and ICSI groups (Tables 2 and 3,
respectively). Because the spermatozoon is injected into
the oocyte in the ICSI procedure, the zona pellucida, cumu-
lus, and corona cell barrier are overcome. This process of
fertilization provides the ICSI embryos a temporal advant-
age of approximately 2–4 h compared with the IVF proce-
dure. The EC rate is higher in ICSI than in IVF (36.8 % vs.
31.0 %, respectively). Thus, the examination of EC should
be performed approximately 23–25 h after ICSI to improve
the accuracy rate of pregnancy prediction in the ICSI group
[7]. We separated the assisted fertilization cases into 2
groups, IVF and ICSI, to investigate the effect of EC on
both groups. The predictive value of using EC embryos as
an indicator of pregnancy outcome is relatively weak, as
mentioned by Van Montfoort et al. [7]. They reported that
many other oocyte and embryonic factors may influence the
implantation capacity of the embryo. In addition, the preg-
nancy outcome is not only dependent on embryo quality but
also on endometrial receptivity.
Embryo selection is a difficult task on the embryo trans-
fer day. Many parameters can be used to make this decision,
including useful tools such as pronuclear morphology, EC,
blastomere morphology, and blastocyst grading. The clinical
outcome of EC embryos should be evaluated when using the
eSET and DET methods. For both IVF and ICSI cycles, the
effect of EC on embryo transfer using mixed embryos
(including EC and non-EC embryos) could not be accurately
evaluated. In our study, we proved that for IVF, EC embryos
(without mixed embryos) develop more normal cleavage
and good quality embryos on day 3, and the selection of
these embryos during IVF results in better clinical out-
comes. Therefore, for IVF, identifying EC embryos is a
useful tool for embryo selection. For the ICSI group, a better
implantation rate was the only clinical outcome using EC
embryos; the differences in the pregnancy and live birth
rates were not statistically significant. Therefore, for ICSI,
EC embryos should be identified 2 h earlier than for IVF to
make this predictive marker more accurate. The use of EC as
a marker for improving rates of pregnancy and live birth
should be further investigated in ICSI cycles.
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